Bioanalysis of peptides service by LGC – DDS
Manufacturer LGC – DDS | Available Worldwide
LGC's bioanalytical solutions have helped their clients develop new peptide therapeutics to improve the quality of life. Applying their experience and cutting-edge technology, LGC have developed and validated methods using LC-MS/MS to quantify levels of peptides in plasma at levels as low as 10 pg/mL.
Bioanalysis of peptides service
LGC have become experts in offering bioanalytical solutions to their clients using LC-MS/MS technology.
LGC's expertise extends beyond determination of peptide drugs in biological matrices. LGC also have experience in the quantitation of proteins (therapeutic drugs and biomarkers) as well as mAbs using LGC's BioMS™ platform.
LGC's ntegrated services include:
- Fast method development for discovery compounds
- Method development and validation for GLP TK studies and GCP clinical trials
- Fast turnaround for Phase I Clinical Studies
- Logistical support for clinical sample management including sample collection kit production and supply of sampling kits, labels, investigator manual and shipping
High quality reporting and data management
- Rapid turnaround of analytical data, draft and final reports, using LGC's templates or yours
- Specialist software to support SEND/SDTM data requirements
- eCTD compliant reports
- PK/TK profiling and reporting using WinNonlin™
- Certified as GLP and GCP compliant by MHRA, successful EMA audits
- Dedicated independent Quality Assurance, pharmacokinetic and data management personnel
Product Overview
Bioanalysis of peptides service
Manufacturer LGC – DDS | Available Worldwide
Be the first to review this product